| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastroesophageal Reflux | 69 | 2021 | 84 | 11.040 |
Why?
|
| Sleep | 52 | 2020 | 112 | 5.300 |
Why?
|
| Sleep Wake Disorders | 31 | 2020 | 65 | 4.960 |
Why?
|
| Esophagus | 36 | 2021 | 72 | 4.170 |
Why?
|
| Sleep Apnea, Obstructive | 15 | 2020 | 44 | 3.390 |
Why?
|
| Heartburn | 24 | 2016 | 26 | 3.070 |
Why?
|
| Peristalsis | 17 | 2021 | 17 | 2.500 |
Why?
|
| Polysomnography | 29 | 2020 | 48 | 2.170 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 5 | 2020 | 24 | 1.820 |
Why?
|
| Inflammatory Bowel Diseases | 4 | 2020 | 44 | 1.640 |
Why?
|
| Irritable Bowel Syndrome | 7 | 2020 | 32 | 1.560 |
Why?
|
| Adult | 110 | 2021 | 8131 | 1.460 |
Why?
|
| Humans | 183 | 2021 | 29214 | 1.450 |
Why?
|
| Colonic Diseases, Functional | 9 | 2002 | 11 | 1.420 |
Why?
|
| Anti-Ulcer Agents | 9 | 2011 | 14 | 1.390 |
Why?
|
| Hydrochloric Acid | 9 | 2016 | 14 | 1.390 |
Why?
|
| Esophageal pH Monitoring | 8 | 2013 | 8 | 1.330 |
Why?
|
| Circadian Rhythm | 13 | 2020 | 76 | 1.260 |
Why?
|
| Male | 110 | 2021 | 14127 | 1.130 |
Why?
|
| Middle Aged | 79 | 2018 | 7496 | 1.110 |
Why?
|
| Female | 105 | 2021 | 15826 | 1.110 |
Why?
|
| Capsaicin | 4 | 2016 | 18 | 1.040 |
Why?
|
| Autonomic Nervous System | 9 | 2006 | 118 | 1.040 |
Why?
|
| Continuous Positive Airway Pressure | 4 | 2014 | 13 | 1.020 |
Why?
|
| Gastric Acid | 11 | 2006 | 19 | 0.960 |
Why?
|
| Gastrointestinal Motility | 10 | 2011 | 30 | 0.940 |
Why?
|
| Sleep Stages | 24 | 2007 | 26 | 0.920 |
Why?
|
| Proton Pump Inhibitors | 8 | 2020 | 27 | 0.920 |
Why?
|
| Manometry | 19 | 2021 | 36 | 0.910 |
Why?
|
| Morpholines | 3 | 2016 | 28 | 0.860 |
Why?
|
| Benzamides | 3 | 2016 | 40 | 0.840 |
Why?
|
| Immune System | 2 | 2014 | 29 | 0.830 |
Why?
|
| Sleep, REM | 20 | 2006 | 21 | 0.830 |
Why?
|
| Omeprazole | 6 | 2005 | 9 | 0.810 |
Why?
|
| Rectum | 7 | 2011 | 50 | 0.800 |
Why?
|
| Myoelectric Complex, Migrating | 8 | 2006 | 9 | 0.800 |
Why?
|
| Hydrogen-Ion Concentration | 24 | 2010 | 271 | 0.790 |
Why?
|
| Heart Rate | 14 | 2006 | 383 | 0.790 |
Why?
|
| Gastrointestinal Diseases | 3 | 2013 | 55 | 0.760 |
Why?
|
| Sleep Apnea Syndromes | 16 | 2004 | 32 | 0.740 |
Why?
|
| Anal Canal | 5 | 2011 | 20 | 0.710 |
Why?
|
| Sleep Deprivation | 6 | 2010 | 28 | 0.700 |
Why?
|
| Biological Clocks | 3 | 2020 | 8 | 0.690 |
Why?
|
| Aged | 38 | 2014 | 5648 | 0.680 |
Why?
|
| Stomach | 10 | 2004 | 43 | 0.660 |
Why?
|
| Airway Obstruction | 9 | 2016 | 20 | 0.650 |
Why?
|
| Esophageal Motility Disorders | 4 | 2013 | 4 | 0.640 |
Why?
|
| Postprandial Period | 10 | 2004 | 51 | 0.630 |
Why?
|
| Severity of Illness Index | 12 | 2014 | 468 | 0.630 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 77 | 0.580 |
Why?
|
| Passeriformes | 1 | 2018 | 4 | 0.570 |
Why?
|
| Dyspepsia | 5 | 2018 | 10 | 0.560 |
Why?
|
| Baclofen | 2 | 2020 | 8 | 0.520 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 5 | 2011 | 9 | 0.510 |
Why?
|
| Surveys and Questionnaires | 17 | 2018 | 1021 | 0.480 |
Why?
|
| Aging | 4 | 2010 | 1041 | 0.470 |
Why?
|
| Case-Control Studies | 10 | 2018 | 741 | 0.460 |
Why?
|
| Histamine H2 Antagonists | 3 | 2003 | 7 | 0.460 |
Why?
|
| Wakefulness | 8 | 2000 | 25 | 0.460 |
Why?
|
| Ranitidine | 7 | 1998 | 9 | 0.450 |
Why?
|
| Gastrointestinal Agents | 2 | 2013 | 16 | 0.440 |
Why?
|
| Pain Threshold | 2 | 2016 | 89 | 0.420 |
Why?
|
| Anxiety Disorders | 1 | 2014 | 66 | 0.420 |
Why?
|
| Young Adult | 11 | 2021 | 2877 | 0.410 |
Why?
|
| Constipation | 5 | 2006 | 22 | 0.410 |
Why?
|
| Eating | 5 | 1998 | 71 | 0.400 |
Why?
|
| Sensation | 3 | 2011 | 12 | 0.400 |
Why?
|
| Obesity | 7 | 2016 | 705 | 0.400 |
Why?
|
| Digestive System Physiological Phenomena | 2 | 2011 | 2 | 0.380 |
Why?
|
| Monitoring, Ambulatory | 4 | 2008 | 26 | 0.370 |
Why?
|
| Cisapride | 3 | 2001 | 3 | 0.370 |
Why?
|
| Esomeprazole | 3 | 2007 | 3 | 0.370 |
Why?
|
| Risk Factors | 11 | 2020 | 2144 | 0.370 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 169 | 0.370 |
Why?
|
| Muscle Relaxants, Central | 1 | 2012 | 11 | 0.360 |
Why?
|
| Treatment Outcome | 11 | 2014 | 2443 | 0.360 |
Why?
|
| Time Factors | 16 | 2016 | 1619 | 0.340 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2011 | 3 | 0.340 |
Why?
|
| Drinking | 3 | 2006 | 8 | 0.330 |
Why?
|
| Hydrocortisone | 2 | 2001 | 89 | 0.330 |
Why?
|
| Sodium Chloride | 1 | 2010 | 68 | 0.320 |
Why?
|
| Posture | 5 | 2008 | 39 | 0.320 |
Why?
|
| Benzimidazoles | 3 | 2005 | 32 | 0.320 |
Why?
|
| Eructation | 2 | 2008 | 2 | 0.310 |
Why?
|
| Double-Blind Method | 11 | 2020 | 426 | 0.310 |
Why?
|
| Adolescent | 17 | 2013 | 3255 | 0.300 |
Why?
|
| Deglutition | 9 | 2004 | 11 | 0.300 |
Why?
|
| Food | 4 | 2005 | 32 | 0.300 |
Why?
|
| Inflammation | 1 | 2013 | 672 | 0.290 |
Why?
|
| Prospective Studies | 8 | 2016 | 1288 | 0.290 |
Why?
|
| Serotonin 5-HT4 Receptor Agonists | 2 | 2020 | 3 | 0.290 |
Why?
|
| Chest Pain | 3 | 1994 | 26 | 0.290 |
Why?
|
| Aerophagy | 1 | 2008 | 1 | 0.290 |
Why?
|
| Consciousness | 1 | 2008 | 6 | 0.280 |
Why?
|
| Digestive System | 3 | 2002 | 16 | 0.280 |
Why?
|
| Sweating | 1 | 2008 | 4 | 0.270 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2008 | 1 | 0.270 |
Why?
|
| Antacids | 2 | 2005 | 6 | 0.270 |
Why?
|
| Comorbidity | 6 | 2009 | 261 | 0.260 |
Why?
|
| Enzyme Inhibitors | 2 | 2005 | 252 | 0.260 |
Why?
|
| Pressure | 7 | 2013 | 91 | 0.250 |
Why?
|
| Quality of Life | 7 | 2013 | 523 | 0.240 |
Why?
|
| Fundoplication | 1 | 2006 | 4 | 0.240 |
Why?
|
| Esophagogastric Junction | 4 | 2010 | 6 | 0.240 |
Why?
|
| Health Status | 3 | 2011 | 149 | 0.230 |
Why?
|
| Deglutition Disorders | 2 | 2005 | 25 | 0.230 |
Why?
|
| Diarrhea | 2 | 2006 | 58 | 0.220 |
Why?
|
| Aged, 80 and over | 8 | 2014 | 2070 | 0.220 |
Why?
|
| Gastrointestinal Tract | 2 | 2020 | 36 | 0.210 |
Why?
|
| Esophagitis, Peptic | 3 | 2006 | 5 | 0.210 |
Why?
|
| Sleep Bruxism | 1 | 2003 | 1 | 0.210 |
Why?
|
| Prognosis | 4 | 2014 | 817 | 0.200 |
Why?
|
| Vagus Nerve | 4 | 2002 | 106 | 0.200 |
Why?
|
| Myocardial Infarction | 3 | 2017 | 351 | 0.190 |
Why?
|
| Lung Diseases, Obstructive | 4 | 1992 | 16 | 0.190 |
Why?
|
| Electrodiagnosis | 4 | 2006 | 5 | 0.190 |
Why?
|
| Muscle, Smooth | 3 | 2004 | 41 | 0.180 |
Why?
|
| Salivation | 2 | 2001 | 11 | 0.180 |
Why?
|
| Efficiency | 4 | 2011 | 18 | 0.180 |
Why?
|
| Famotidine | 2 | 1994 | 3 | 0.170 |
Why?
|
| Codeine | 1 | 2021 | 3 | 0.170 |
Why?
|
| Respiration | 9 | 1994 | 45 | 0.170 |
Why?
|
| Menthol | 1 | 2021 | 18 | 0.170 |
Why?
|
| Affect | 2 | 2001 | 85 | 0.170 |
Why?
|
| Mental Disorders | 1 | 2002 | 118 | 0.170 |
Why?
|
| Benzofurans | 1 | 2020 | 6 | 0.170 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2020 | 2 | 0.170 |
Why?
|
| Sildenafil Citrate | 1 | 2020 | 4 | 0.170 |
Why?
|
| Electrocardiography | 11 | 2006 | 398 | 0.160 |
Why?
|
| Prevalence | 4 | 2018 | 526 | 0.160 |
Why?
|
| Healthy Volunteers | 1 | 2020 | 50 | 0.160 |
Why?
|
| Apnea | 6 | 1986 | 13 | 0.160 |
Why?
|
| Receptors, Serotonin, 5-HT4 | 3 | 2020 | 4 | 0.160 |
Why?
|
| Hypnotics and Sedatives | 1 | 2020 | 29 | 0.150 |
Why?
|
| Primary Health Care | 2 | 2012 | 169 | 0.150 |
Why?
|
| Stress, Psychological | 2 | 2001 | 235 | 0.150 |
Why?
|
| Monitoring, Physiologic | 7 | 1995 | 58 | 0.150 |
Why?
|
| Snoring | 5 | 1992 | 8 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2013 | 614 | 0.150 |
Why?
|
| Arousal | 4 | 2000 | 38 | 0.150 |
Why?
|
| Heart | 1 | 2000 | 232 | 0.150 |
Why?
|
| Rabeprazole | 3 | 2009 | 4 | 0.140 |
Why?
|
| Jet Lag Syndrome | 1 | 2018 | 1 | 0.140 |
Why?
|
| Fourier Analysis | 3 | 2006 | 31 | 0.140 |
Why?
|
| Taiwan | 4 | 2020 | 7 | 0.140 |
Why?
|
| Cohort Studies | 5 | 2020 | 903 | 0.140 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 142 | 0.140 |
Why?
|
| Mastication | 1 | 1998 | 4 | 0.140 |
Why?
|
| Arrhythmias, Cardiac | 6 | 1986 | 168 | 0.130 |
Why?
|
| Food, Formulated | 1 | 1997 | 11 | 0.130 |
Why?
|
| Esophageal Diseases | 3 | 1988 | 13 | 0.130 |
Why?
|
| Cross-Sectional Studies | 5 | 2018 | 1013 | 0.130 |
Why?
|
| Signal Processing, Computer-Assisted | 4 | 2000 | 69 | 0.130 |
Why?
|
| Feeding Behavior | 1 | 1998 | 104 | 0.130 |
Why?
|
| Hypoxia | 3 | 1990 | 90 | 0.130 |
Why?
|
| Esophagitis | 3 | 2003 | 7 | 0.130 |
Why?
|
| Animals | 7 | 2018 | 10806 | 0.130 |
Why?
|
| Reference Values | 4 | 2005 | 200 | 0.130 |
Why?
|
| Sensory System Agents | 1 | 2016 | 2 | 0.130 |
Why?
|
| Drug Administration Schedule | 6 | 2011 | 225 | 0.120 |
Why?
|
| TRPV Cation Channels | 1 | 2016 | 16 | 0.120 |
Why?
|
| Cross-Over Studies | 2 | 2012 | 139 | 0.120 |
Why?
|
| Instillation, Drug | 1 | 2016 | 7 | 0.120 |
Why?
|
| Mechanoreceptors | 1 | 2016 | 10 | 0.120 |
Why?
|
| Air | 1 | 2016 | 23 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2010 | 632 | 0.110 |
Why?
|
| Muscle Contraction | 3 | 2011 | 175 | 0.110 |
Why?
|
| Data Interpretation, Statistical | 2 | 2010 | 58 | 0.110 |
Why?
|
| Administration, Oral | 3 | 2011 | 191 | 0.110 |
Why?
|
| Acute Disease | 4 | 2017 | 158 | 0.110 |
Why?
|
| Positive-Pressure Respiration | 2 | 1993 | 14 | 0.110 |
Why?
|
| Colon | 3 | 2005 | 123 | 0.110 |
Why?
|
| Electrophysiology | 6 | 2004 | 150 | 0.110 |
Why?
|
| Narcolepsy | 2 | 2010 | 7 | 0.110 |
Why?
|
| Pain Measurement | 2 | 2016 | 172 | 0.110 |
Why?
|
| Cimetidine | 1 | 1994 | 2 | 0.100 |
Why?
|
| Respiration Disorders | 1 | 1994 | 7 | 0.100 |
Why?
|
| Telemetry | 1 | 1994 | 8 | 0.100 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 485 | 0.100 |
Why?
|
| Serotonin 5-HT3 Receptor Agonists | 1 | 2013 | 1 | 0.100 |
Why?
|
| Quinuclidines | 1 | 2013 | 10 | 0.100 |
Why?
|
| Meals | 1 | 2013 | 23 | 0.100 |
Why?
|
| Depression | 3 | 2018 | 234 | 0.100 |
Why?
|
| Crohn Disease | 1 | 2013 | 32 | 0.100 |
Why?
|
| Colitis, Ulcerative | 1 | 2013 | 31 | 0.100 |
Why?
|
| Gastric Acidity Determination | 3 | 2006 | 4 | 0.100 |
Why?
|
| Chronic Disease | 2 | 2009 | 274 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2018 | 100 | 0.100 |
Why?
|
| Saliva | 2 | 2004 | 96 | 0.090 |
Why?
|
| Pyridines | 1 | 2013 | 108 | 0.090 |
Why?
|
| Electromyography | 7 | 1998 | 176 | 0.090 |
Why?
|
| Neuropsychological Tests | 3 | 2011 | 249 | 0.090 |
Why?
|
| Age Factors | 3 | 2010 | 740 | 0.090 |
Why?
|
| Brain | 1 | 1997 | 774 | 0.090 |
Why?
|
| Disorders of Excessive Somnolence | 5 | 1984 | 8 | 0.090 |
Why?
|
| Esophagoscopy | 2 | 2010 | 16 | 0.090 |
Why?
|
| HLA-D Antigens | 1 | 1991 | 6 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2013 | 1033 | 0.080 |
Why?
|
| Analysis of Variance | 3 | 2008 | 393 | 0.080 |
Why?
|
| Interviews as Topic | 1 | 2012 | 164 | 0.080 |
Why?
|
| Genetic Markers | 1 | 1991 | 92 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2008 | 526 | 0.080 |
Why?
|
| Suspensions | 1 | 2010 | 7 | 0.080 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2010 | 11 | 0.080 |
Why?
|
| Gastrointestinal Transit | 1 | 2010 | 8 | 0.080 |
Why?
|
| Logistic Models | 1 | 2012 | 415 | 0.080 |
Why?
|
| Magnetoencephalography | 1 | 2011 | 28 | 0.080 |
Why?
|
| Family Practice | 1 | 2011 | 47 | 0.080 |
Why?
|
| Metoclopramide | 1 | 1990 | 3 | 0.080 |
Why?
|
| Allium | 1 | 1990 | 2 | 0.080 |
Why?
|
| Dyssomnias | 1 | 2010 | 1 | 0.080 |
Why?
|
| Mass Screening | 2 | 2009 | 160 | 0.080 |
Why?
|
| Rest | 1 | 2011 | 96 | 0.080 |
Why?
|
| Multivariate Analysis | 3 | 2011 | 303 | 0.080 |
Why?
|
| Laryngoscopy | 1 | 2009 | 6 | 0.080 |
Why?
|
| Respiratory System | 1 | 2009 | 13 | 0.080 |
Why?
|
| Tarsal Tunnel Syndrome | 1 | 2009 | 1 | 0.070 |
Why?
|
| Hydrocodone | 1 | 2009 | 3 | 0.070 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2009 | 6 | 0.070 |
Why?
|
| Acetazolamide | 1 | 2009 | 9 | 0.070 |
Why?
|
| Sleep Apnea, Central | 1 | 2009 | 17 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2008 | 2662 | 0.070 |
Why?
|
| Gastric Juice | 3 | 1981 | 4 | 0.070 |
Why?
|
| Colitis | 1 | 2009 | 54 | 0.070 |
Why?
|
| Fentanyl | 1 | 2009 | 35 | 0.070 |
Why?
|
| Electroencephalography | 10 | 1990 | 144 | 0.070 |
Why?
|
| Barrett Esophagus | 1 | 1988 | 16 | 0.070 |
Why?
|
| Alzheimer Disease | 1 | 2011 | 225 | 0.070 |
Why?
|
| Reaction Time | 3 | 2001 | 95 | 0.070 |
Why?
|
| Restless Legs Syndrome | 1 | 2008 | 3 | 0.070 |
Why?
|
| Clothing | 1 | 2008 | 4 | 0.070 |
Why?
|
| Plethysmography, Impedance | 1 | 2008 | 17 | 0.070 |
Why?
|
| Postoperative Complications | 2 | 1987 | 643 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2009 | 198 | 0.070 |
Why?
|
| Child, Preschool | 4 | 1998 | 1215 | 0.070 |
Why?
|
| Analgesics, Opioid | 1 | 2009 | 121 | 0.070 |
Why?
|
| Pharynx | 1 | 1987 | 15 | 0.070 |
Why?
|
| Fatigue | 1 | 2008 | 66 | 0.070 |
Why?
|
| Cleft Palate | 1 | 1987 | 15 | 0.060 |
Why?
|
| Surgical Flaps | 1 | 1987 | 24 | 0.060 |
Why?
|
| Parasympatholytics | 1 | 1987 | 13 | 0.060 |
Why?
|
| Fecal Incontinence | 2 | 2002 | 16 | 0.060 |
Why?
|
| Electric Impedance | 1 | 2007 | 31 | 0.060 |
Why?
|
| Calcium Channel Blockers | 1 | 1987 | 41 | 0.060 |
Why?
|
| Ambulatory Care | 1 | 2006 | 63 | 0.060 |
Why?
|
| Caffeine | 1 | 1986 | 39 | 0.060 |
Why?
|
| Infant, Newborn | 4 | 1997 | 932 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2008 | 416 | 0.060 |
Why?
|
| Child | 4 | 1998 | 2355 | 0.060 |
Why?
|
| Intestine, Small | 2 | 2002 | 66 | 0.060 |
Why?
|
| Metabolic Clearance Rate | 2 | 2001 | 18 | 0.060 |
Why?
|
| Research Design | 1 | 1987 | 188 | 0.060 |
Why?
|
| Heart Conduction System | 1 | 2006 | 270 | 0.060 |
Why?
|
| Sulfoxides | 1 | 2005 | 6 | 0.060 |
Why?
|
| Probability | 1 | 2005 | 78 | 0.050 |
Why?
|
| Laparoscopy | 1 | 2006 | 159 | 0.050 |
Why?
|
| Smoking | 2 | 1986 | 480 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2005 | 382 | 0.050 |
Why?
|
| Palatine Tonsil | 2 | 1981 | 10 | 0.050 |
Why?
|
| Fasting | 3 | 1998 | 91 | 0.050 |
Why?
|
| Perception | 1 | 2004 | 92 | 0.050 |
Why?
|
| Gastric Mucosa | 3 | 1998 | 35 | 0.050 |
Why?
|
| Life Style | 1 | 2004 | 91 | 0.050 |
Why?
|
| Incidence | 1 | 2005 | 581 | 0.050 |
Why?
|
| Electrodes | 2 | 2003 | 72 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 210 | 0.050 |
Why?
|
| Progesterone | 2 | 1985 | 130 | 0.050 |
Why?
|
| Equipment and Supplies | 2 | 1997 | 12 | 0.050 |
Why?
|
| Thorax | 1 | 1982 | 29 | 0.050 |
Why?
|
| Receptors, Gastrointestinal Hormone | 1 | 2002 | 3 | 0.050 |
Why?
|
| Receptors, Neuropeptide | 1 | 2002 | 4 | 0.050 |
Why?
|
| Erythromycin | 1 | 2002 | 15 | 0.050 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2015 | 29 | 0.040 |
Why?
|
| Myxedema | 1 | 1981 | 1 | 0.040 |
Why?
|
| Digestion | 2 | 1996 | 15 | 0.040 |
Why?
|
| Asthma | 1 | 2002 | 61 | 0.040 |
Why?
|
| Autonomic Pathways | 1 | 2001 | 16 | 0.040 |
Why?
|
| Endoscopy | 1 | 2021 | 57 | 0.040 |
Why?
|
| Sex Factors | 1 | 2002 | 473 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2010 | 145 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2020 | 79 | 0.040 |
Why?
|
| Electrooculography | 4 | 1990 | 5 | 0.040 |
Why?
|
| Pain | 1 | 1982 | 258 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2018 | 15 | 0.040 |
Why?
|
| Neck Injuries | 1 | 1998 | 8 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 1999 | 175 | 0.040 |
Why?
|
| Placebos | 1 | 1998 | 48 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 271 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 1998 | 82 | 0.040 |
Why?
|
| Health Surveys | 2 | 2010 | 88 | 0.040 |
Why?
|
| Linear Models | 1 | 2018 | 204 | 0.030 |
Why?
|
| Spinal Cord Injuries | 1 | 1998 | 69 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2015 | 358 | 0.030 |
Why?
|
| Activities of Daily Living | 2 | 2010 | 107 | 0.030 |
Why?
|
| Pulmonary Ventilation | 2 | 1990 | 11 | 0.030 |
Why?
|
| Anxiety | 1 | 2018 | 167 | 0.030 |
Why?
|
| Age Distribution | 1 | 2017 | 75 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 78 | 0.030 |
Why?
|
| Coronary Care Units | 2 | 1992 | 2 | 0.030 |
Why?
|
| Actigraphy | 1 | 2016 | 22 | 0.030 |
Why?
|
| Mental Recall | 1 | 1997 | 51 | 0.030 |
Why?
|
| Pain Perception | 1 | 2016 | 17 | 0.030 |
Why?
|
| Capsicum | 1 | 2016 | 2 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 194 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 1977 | 68 | 0.030 |
Why?
|
| Growth Hormone | 1 | 1977 | 103 | 0.030 |
Why?
|
| Child Development | 1 | 1997 | 79 | 0.030 |
Why?
|
| Tracheotomy | 3 | 1985 | 3 | 0.030 |
Why?
|
| Sleep Disorders, Intrinsic | 1 | 2015 | 2 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2015 | 9 | 0.030 |
Why?
|
| Lipoproteins, HDL | 1 | 2015 | 41 | 0.030 |
Why?
|
| Philosophy, Medical | 1 | 1994 | 3 | 0.030 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1975 | 117 | 0.030 |
Why?
|
| Tonsillectomy | 3 | 1985 | 10 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 1975 | 109 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 1974 | 43 | 0.030 |
Why?
|
| Metabolic Syndrome | 1 | 2015 | 80 | 0.030 |
Why?
|
| Drug Tolerance | 1 | 1994 | 37 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2015 | 105 | 0.030 |
Why?
|
| Laboratories | 1 | 1994 | 18 | 0.030 |
Why?
|
| Drug Partial Agonism | 1 | 2013 | 2 | 0.030 |
Why?
|
| United States | 2 | 2010 | 2270 | 0.020 |
Why?
|
| Movement | 1 | 1994 | 100 | 0.020 |
Why?
|
| Leg | 1 | 1994 | 134 | 0.020 |
Why?
|
| Airway Resistance | 1 | 1992 | 4 | 0.020 |
Why?
|
| Infant | 2 | 1985 | 1067 | 0.020 |
Why?
|
| Chromosome Disorders | 1 | 1991 | 5 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 1991 | 35 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1991 | 37 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 1994 | 794 | 0.020 |
Why?
|
| Lansoprazole | 1 | 2011 | 1 | 0.020 |
Why?
|
| Dexlansoprazole | 1 | 2011 | 1 | 0.020 |
Why?
|
| Pedigree | 1 | 1991 | 156 | 0.020 |
Why?
|
| Dogs | 2 | 2003 | 510 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 1990 | 17 | 0.020 |
Why?
|
| Absenteeism | 1 | 2010 | 7 | 0.020 |
Why?
|
| Cognition | 3 | 2010 | 331 | 0.020 |
Why?
|
| Work Schedule Tolerance | 1 | 2010 | 11 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2010 | 21 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2010 | 69 | 0.020 |
Why?
|
| Employment | 1 | 2010 | 49 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2010 | 56 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2011 | 208 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2009 | 19 | 0.020 |
Why?
|
| Disease Progression | 1 | 2011 | 484 | 0.020 |
Why?
|
| Activator Appliances | 1 | 1988 | 2 | 0.020 |
Why?
|
| Orthodontic Appliances, Removable | 1 | 1988 | 2 | 0.020 |
Why?
|
| Multiple Sclerosis | 1 | 2010 | 92 | 0.020 |
Why?
|
| Internet | 1 | 2009 | 129 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1990 | 415 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 303 | 0.020 |
Why?
|
| Nifedipine | 1 | 1987 | 12 | 0.020 |
Why?
|
| Atropine | 1 | 1987 | 47 | 0.020 |
Why?
|
| Maternal Age | 1 | 1986 | 25 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2007 | 91 | 0.020 |
Why?
|
| Birth Weight | 1 | 1986 | 63 | 0.010 |
Why?
|
| Cost Control | 1 | 1985 | 9 | 0.010 |
Why?
|
| Protriptyline | 1 | 1985 | 1 | 0.010 |
Why?
|
| Hyoid Bone | 1 | 1985 | 2 | 0.010 |
Why?
|
| Tongue | 1 | 1985 | 7 | 0.010 |
Why?
|
| Nasal Cavity | 1 | 1985 | 21 | 0.010 |
Why?
|
| Sudden Infant Death | 1 | 1985 | 3 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1985 | 116 | 0.010 |
Why?
|
| Patient Care Team | 1 | 1985 | 66 | 0.010 |
Why?
|
| Menstrual Cycle | 1 | 1985 | 24 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 1986 | 136 | 0.010 |
Why?
|
| Body Weight | 1 | 1985 | 253 | 0.010 |
Why?
|
| Syndrome | 3 | 1980 | 79 | 0.010 |
Why?
|
| Dreams | 2 | 1982 | 9 | 0.010 |
Why?
|
| Respiratory Mechanics | 1 | 2004 | 17 | 0.010 |
Why?
|
| Pharyngeal Muscles | 1 | 1983 | 1 | 0.010 |
Why?
|
| Hypopharynx | 1 | 1983 | 2 | 0.010 |
Why?
|
| Muscle Hypotonia | 1 | 1983 | 4 | 0.010 |
Why?
|
| Defecation | 1 | 2002 | 11 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 553 | 0.010 |
Why?
|
| Safety | 1 | 2002 | 33 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2002 | 48 | 0.010 |
Why?
|
| Reflex, Stretch | 1 | 1982 | 3 | 0.010 |
Why?
|
| Pregnancy | 1 | 1986 | 1261 | 0.010 |
Why?
|
| Phenobarbital | 1 | 1981 | 4 | 0.010 |
Why?
|
| Craniocerebral Trauma | 1 | 1982 | 27 | 0.010 |
Why?
|
| Death, Sudden | 2 | 1979 | 15 | 0.010 |
Why?
|
| Hypertrophy | 1 | 1981 | 46 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1981 | 13 | 0.010 |
Why?
|
| Thyroxine | 1 | 1981 | 11 | 0.010 |
Why?
|
| Oropharynx | 1 | 1981 | 4 | 0.010 |
Why?
|
| Flurazepam | 1 | 1981 | 1 | 0.010 |
Why?
|
| Hypertension | 1 | 1983 | 309 | 0.010 |
Why?
|
| Muscles | 1 | 1981 | 73 | 0.010 |
Why?
|
| Lung | 2 | 1980 | 389 | 0.010 |
Why?
|
| Cough | 1 | 1980 | 11 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 2000 | 68 | 0.010 |
Why?
|
| Oxygen | 1 | 1981 | 238 | 0.010 |
Why?
|
| Cholesterol | 1 | 1981 | 204 | 0.010 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 1999 | 15 | 0.010 |
Why?
|
| N-Formylmethionine | 1 | 1979 | 1 | 0.010 |
Why?
|
| Complement C5 | 1 | 1979 | 4 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1979 | 9 | 0.010 |
Why?
|
| Methionine | 1 | 1979 | 38 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2000 | 239 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1999 | 256 | 0.010 |
Why?
|
| Risk | 1 | 1979 | 138 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1979 | 94 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1979 | 97 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1979 | 190 | 0.010 |
Why?
|
| Pneumonia | 1 | 1979 | 89 | 0.010 |
Why?
|
| Dietary Fiber | 1 | 1998 | 12 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1979 | 136 | 0.010 |
Why?
|
| Energy Intake | 1 | 1998 | 69 | 0.010 |
Why?
|
| Adenoids | 1 | 1977 | 1 | 0.010 |
Why?
|
| Retrognathia | 1 | 1977 | 5 | 0.010 |
Why?
|
| Pneumonectomy | 1 | 1977 | 11 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1977 | 68 | 0.010 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 1976 | 23 | 0.010 |
Why?
|
| Duodenal Ulcer | 1 | 1976 | 5 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1977 | 81 | 0.010 |
Why?
|
| Gastrins | 1 | 1976 | 28 | 0.010 |
Why?
|
| Esophageal Achalasia | 1 | 1996 | 6 | 0.010 |
Why?
|
| Arrhythmia, Sinus | 1 | 1975 | 4 | 0.010 |
Why?
|
| Nitroglycerin | 1 | 1975 | 27 | 0.010 |
Why?
|
| MMPI | 1 | 1974 | 2 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 1974 | 27 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1974 | 104 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1974 | 80 | 0.010 |
Why?
|
| Attention | 1 | 1974 | 91 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 1974 | 97 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 1974 | 177 | 0.010 |
Why?
|
| Hyalin | 1 | 1973 | 2 | 0.010 |
Why?
|
| Cholestasis | 1 | 1973 | 13 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 1973 | 78 | 0.010 |
Why?
|
| Liver | 1 | 1973 | 497 | 0.000 |
Why?
|
| Psychophysiologic Disorders | 2 | 1982 | 6 | 0.000 |
Why?
|
| Cephalometry | 1 | 1988 | 28 | 0.000 |
Why?
|
| Respiratory Function Tests | 1 | 1988 | 27 | 0.000 |
Why?
|
| Computers | 1 | 1988 | 31 | 0.000 |
Why?
|
| Equipment Design | 1 | 1988 | 218 | 0.000 |
Why?
|
| Water | 1 | 1988 | 135 | 0.000 |
Why?
|
| Mucous Membrane | 1 | 1987 | 28 | 0.000 |
Why?
|
| Random Allocation | 1 | 1987 | 152 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1987 | 221 | 0.000 |
Why?
|
| Administration, Topical | 1 | 1985 | 31 | 0.000 |
Why?
|
| Hormones | 1 | 1985 | 44 | 0.000 |
Why?
|
| Intestinal Absorption | 1 | 1983 | 5 | 0.000 |
Why?
|
| Cholecystokinin | 1 | 1983 | 6 | 0.000 |
Why?
|
| Cats | 1 | 1983 | 52 | 0.000 |
Why?
|
| Tryptophan | 1 | 1983 | 42 | 0.000 |
Why?
|
| Sensory Thresholds | 1 | 1982 | 14 | 0.000 |
Why?
|
| Neural Inhibition | 1 | 1982 | 48 | 0.000 |
Why?
|
| Memory | 1 | 1982 | 76 | 0.000 |
Why?
|
| Motor Activity | 1 | 1981 | 149 | 0.000 |
Why?
|
| Lung Compliance | 1 | 1980 | 3 | 0.000 |
Why?
|
| Emotions | 1 | 1981 | 139 | 0.000 |
Why?
|
| Pulmonary Edema | 1 | 1979 | 9 | 0.000 |
Why?
|
| Hemoptysis | 1 | 1979 | 2 | 0.000 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1979 | 14 | 0.000 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1979 | 15 | 0.000 |
Why?
|
| Serum Albumin | 1 | 1979 | 36 | 0.000 |
Why?
|
| Intubation, Intratracheal | 1 | 1979 | 27 | 0.000 |
Why?
|
| Cricetinae | 1 | 1979 | 131 | 0.000 |
Why?
|
| Rabbits | 1 | 1979 | 281 | 0.000 |
Why?
|
| Adenoidectomy | 1 | 1977 | 4 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1977 | 32 | 0.000 |
Why?
|
| Environment | 1 | 1976 | 66 | 0.000 |
Why?
|
| Heart Auscultation | 1 | 1974 | 2 | 0.000 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1976 | 173 | 0.000 |
Why?
|
| Aortic Valve Stenosis | 1 | 1974 | 85 | 0.000 |
Why?
|
| Hepatolenticular Degeneration | 1 | 1973 | 1 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1973 | 94 | 0.000 |
Why?
|
| Microscopy | 1 | 1973 | 38 | 0.000 |
Why?
|
| Liver Diseases | 1 | 1973 | 52 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1976 | 384 | 0.000 |
Why?
|